<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Settlements on FinanClub</title>
    <link>https://finan.club/tags/settlements/</link>
    <description>Recent content in Settlements on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 11 Sep 2023 05:50:15 +0000</lastBuildDate><atom:link href="https://finan.club/tags/settlements/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>TEVA</title>
      <link>https://finan.club/us/teva/</link>
      <pubDate>Mon, 11 Sep 2023 05:50:15 +0000</pubDate>
      
      <guid>https://finan.club/us/teva/</guid>
      <description>score:7
Chances: Teva Pharmaceutical Industries is set to present data for various products, indicating ongoing research and potential for growth. Teva&amp;rsquo;s CEO sees &amp;lsquo;significant&amp;rsquo; potential for a trio of branded drugs, which could drive future revenue and profits. Teva&amp;rsquo;s strategic evaluation, including the potential sale of its active ingredients unit, might create opportunities for restructuring and focus on core operations.</description>
    </item>
    
  </channel>
</rss>
